Zeiss Group Reports Double Digit Revenue Growth in First Half of Fiscal Year

By Staff
Friday, May 17, 2024 12:21 AM OBERKOCHEN, Germany—The Zeiss Group (CZMWY) has reported the results of the first half of fiscal year 2023/24. The group generated revenue totaling €5.304 million for the period ended March 31, 2024, which is an increase of 10 percent compared with the comparable period the previous year. All four Zeiss segments contributed to the company's growth, Zeiss noted. Earnings before interest and taxes (EBIT) totaled €739 million, compared with €-178 million in the prior-year period. Expenditures on research and development remained at 15 percent of revenue, according to the company.

ClearVision Is Named One of the Best Companies to Work for in New York for Ninth Time

By Staff
Thursday, May 16, 2024 12:18 AM HAUPPAUGE, N.Y.—ClearVision Optical was recognized for the ninth time as one of the Best Companies to Work for in New York by the New York State Society for Human Resource Management (NYS-SHRM) and Best Companies Group.

Deadline Is Extended to May 22 for Jobson’s 2024 'Ultimate Partners' Program—Nominate a Supportive Business Partner Now

By Staff
Thursday, May 16, 2024 12:15 AM NEW YORK—The readers of Vision Monday and 20/20 Magazine are being asked once again to share nominations to tell their stories for the Ultimate Partners annual editorial initiative. The deadline for submissions has been extended to May 22. Now in its fourth year, Jobson’s 2024 Ultimate Partners program allows readers to highlight their great business support partners and showcase their support. Open to all eyecare professionals, the program is looking to spotlight your most successful collaborations and celebrate the crucial support shared during both challenges and opportunities.

Harrow Reports Growth in First Quarter of 2024, Restates Commitment to Building Its Dry Eye Disease Franchise

By Staff
Wednesday, May 15, 2024 12:21 AM NASHVILLE, Tenn.—Harrow, a U.S. eyecare pharmaceutical company, (Nasdaq: HROW) has announced its results for the first quarter ended March 31, 2024. In the first quarter of 2024, Harrow recorded revenues of $34.6 million, a 33 percent increase over the $26.1 million realized in the prior-year quarter.

Accessories Council Celebrates 30th Anniversary and 2024 Honorees at Annual ACE Awards

By Staff
Tuesday, May 14, 2024 12:24 AM NEW YORK—The Accessories Council hosted its annual Accessories Council Excellence Awards (ACE) Awards on May 7, 2024, at the Pierre Hotel in New York City. The organization also celebrated its 30th anniversary at the sold-out gala, marking three decades of recognizing individuals and companies who have made great strides in raising awareness of the accessories industry. The 2024 event honored ACE Award recipients across 11 categories, spotlighting global brands and pioneers and positioning them at the forefront of the fashion industry. In the eyewear industry, Foster Grant was awarded the Legacy Award.

Mondottica Awarded ISO 9001 Certification

By Staff
Tuesday, May 14, 2024 12:15 AM NOTTINGHAM, U.K.—Mondottica has announced that the company has been awarded ISO 9001:2015 certification, an internationally recognized standard that ensures that its products and services meet the needs of partners and customers through an effective quality management system (QMS).

Marcolin Reports Consolidation of License Portfolio, Growing Margins in First Quarter of 2024

By Staff
Friday, May 10, 2024 12:24 AM LONGARONE and MILAN, Italy—The board of directors of Marcolin approved the economic and financial results of the group as of March 31, 2024. In the first three months of 2024, Marcolin has continued to consolidate its performances, in line with the results registered in 2023, carrying out its growth path undertaken in recent years.

Safilo Group Reports Positive Start to Year in Europe, Subdued Sports and Eyewear Contemporary Segments in North America

By Staff
Wednesday, May 8, 2024 12:27 AM PADUA—The board of directors of Safilo Group S.p.A. yesterday reviewed and approved Q1 2024 economic and financial key performance indicators, according to an announcement from the company. Angelo Trocchia, Safilo’s chief executive officer, said, “In a business environment which is still complex and uncertain, it was again a positive start to the year for our European business, supported by the brilliant growth of Carrera, which has made its debut in our main markets with a  brand new women's collection that is gathering excellent feedback, and David Beckham, which continued to register strong progress in the global premium segment. In North America, sales were affected by a subdued winter season for the sports business and a wholesale eyewear market that remained weak in the contemporary segment, while the direct-to-consumer channel of both Blenders and Smith continued to grow nicely.

Nominate a Supportive Business Partner for the 20/20 Magazine and Vision Monday 2024 'Ultimate Partners' Program

By Staff
Wednesday, May 8, 2024 12:15 AM NEW YORK—The readers of Vision Monday and 20/20 Magazine are being asked once again to share nominations for their Ultimate Partners. The deadline for submissions is May 15. Now in it's fourth year, Jobson’s 2024 Ultimate Partners program allows readers to highlight their great business support partners and showcase their support. Open to all eyecare professionals, the program is looking to spotlight your most successful collaborations and celebrate the crucial support shared during both challenges and opportunities.

Marcolin and K-Way Sign Exclusive Licensing Agreement

By Staff
Tuesday, May 7, 2024 12:24 AM LONGARONE and MILAN, Italy—Marcolin and K-Way, a French brand currently owned by Turin-based group BasicNet, announced they have signed an exclusive licensing agreement for the design, production and worldwide distribution of K-Way brand sunglasses, optical frames, ski goggles and eyewear for kids. The partnership officially begins on January 1, 2025, and will last six years.

Safilo Signs Perpetual License Agreement for David Beckham Eyewear

By Staff
Friday, May 3, 2024 12:21 AM PADUA, Italy—Safilo Group reported yesterday that the company has signed a perpetual license agreement with Authentic Brands Group (Authentic) for David Beckham Eyewear, which substitutes the previous contract expiring at the end of 2030.

Safilo North America Names Gabriele Cusani Sodano President and Chief Commercial Officer

By Staff
Thursday, May 2, 2024 12:30 AM SECAUCUS, N.J.—Safilo North America has announced the appointment of Gabriele Cusani Sodano as president and chief commercial officer, effective April 2024. Cusani brings a wealth of experience and a proven track record to succeed in this new role, which will focus on accelerating the implementation of the Group’s strategic plan in the North American market, the company stated. He joined Safilo in 2015 and has held various roles of increasing responsibility throughout his tenure, with experience that spans commercial strategy and planning, brand management, business development, sales operations and direct to consumer.

EssilorLuxottica’s Annual Shareholders Meeting Approves All Resolutions, Reappoints Board

By Staff
Wednesday, May 1, 2024 12:30 AM CHARENTON-LE-PONT, France—EssilorLuxottica held its annual shareholders meeting yesterday in Paris, the company announced, where shareholders approved all 34 resolutions submitted by the board of directors to the Ordinary and Extraordinary General Meeting. These included the distribution of a €3.95 dividend per share for the financial year 2023, the compensation policy applicable to the company’s executive corporate officers and the reappointment of all previous directors to the new board of directors. “On behalf of the board of directors, we would like to extend warm thanks to our shareholders for their continued support and trust," said Francesco Milleri, chairman and CEO, and Paul du Saillant, deputy CEO at EssilorLuxottica.

Qlaris Bio Completes $24 Million Series B Financing Round to Advance QLS-111, an IOP-Lowering Drug Candidate for Glaucoma

By Staff
Wednesday, May 1, 2024 12:18 AM DEDHAM, Mass.—Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, has announced the close of a $24 million Series B financing round.

Wiley X Expands Sales Team By More Than 100, Names Aaron Quigley Senior Vice President of Sales

By Staff
Tuesday, April 30, 2024 12:24 AM FRISCO, Texas—Wiley X has restructured and expanded its sales team to enhance the brand’s relationships and support across retail partners and customers.